openPR Logo
Press release

Forecasting the Industrial Analysis and Upcoming Market Trends of Vasomotor Symptoms of Menopause till 2024

01-25-2017 06:49 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Forecasting the Industrial Analysis and Upcoming Market Trends

Global Vasomotor Symptoms of Menopause Market: Overview

Menopause is the stage during which women stop producing ovaries and there is an end of the fertile phase. It occurs in 85% of premenopausal women during their late 40s, resulting in the cessation of their menstrual cycle. Due to the cessation of menstrual flow, the production of estrogen decreases and gonadotropin increases, which gives rise to various physiological and psychological changes, called vasomotor symptoms. Vasomotor symptoms of menopause are the actions which are related to nerves and muscles that cause the blood vessels to dilate. Vasomotor symptoms of menopause are basically a transition between two phases: perimenopause and menopause. The major vasomotor symptoms associated with menopause are listed below:

Hot flashes:

Hot flash is one of the most frequent symptoms of menopause. During this condition, women feel enormous intensity of heat accompanied with excessive sweating. Hot flashes with sweating also occur at night and the condition is termed as night sweats which disturbs the sleep pattern of an individual.

Obtain the Upcoming Market Trends of Vasomotor Symptoms of Menopause at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=15731

Formication:

Formication is basically a form of paresthesia which results in an abnormal skin sensation, illusion or hallucination that some insects are crawling over the skin. It causes feelings of itchiness, tingling or even burning on the skin.

Migraine:

Due to the hormonal fluctuations of menstrual cycle, migraine headaches pose a serious impediment to women undergoing menopausal phase. They are a form of recurrent headaches that can last from few hours up to three days.

Dysfunctional uterine bleeding:

Due to abrupt changes in hormonal levels, ovulation becomes inconsistent causing endometrial hyperplasia to develop and result in abnormal bleeding.

Psychological symptoms:

There are a number of psychological symptoms associated with onset of menopause such as fatigue, anxiety, irritability, mood swings, insomnia etc.

Global Vasomotor Symptoms of Menopause Market: Segmentation

There are various therapies related to vasomotor symptoms of menopause and henceforth the market can be segmented as follows:

Hormone Replacement Therapy (HRT):

HRT is a hormone therapy which is given to women whose estrogen and progesterone hormone level have dropped enormously

Selective estrogen receptor modulators (SERM):

SERMs are a type of drugs that block the effect of estrogen in the breast cells and activate the action of estrogen in other cells such as uterine cells

Gabapentin:

They are a type of medications which reduces the effect of hot flash and night sweats

Antidepressants:

Few vasomotor symptoms are relieved with the aid of antidepressants. Example: fluoxetine and venlafaxine.

The driving factors that will augment the growth of menopausal symptoms therapeutics market are introduction of new treatments and therapies in the market, increasing awareness among female patients about their health and use of non-hormonal therapies.

Global Vasomotor Symptoms of Menopause Market: Geographical Dynamics

Geographically, North America dominates the menopause therapeutics market followed by Europe. According to NutritionMD, about 40% of North American women seek treatment for menopausal symptoms. Increasing cases of menopausal symptoms and the rising need of women population to go for novel therapies are the major factors, which have driven the growth of the menopausal symptoms therapeutic market. Asia-Pacific is one of the most rapidly developing region and the prime factors that will drive the growth of menopausal symptoms therapeutics market in this region are increasing geriatric female population with menopause disorders, and a shift in preference from hormonal therapies to non-hormonal therapies that will create an opportunity for many pharmaceutical companies to develop novel technologies and therapies.

Read the Current Market Analysis of Vasomotor Symptoms of Menopause at: http://www.transparencymarketresearch.com/vasomotor-symptoms-menopause-market.html

Global Vasomotor Symptoms of Menopause Market: Company Profiles

Some of the top market players of this market are Eli Lilly and Company. Procter & Gamble, Pfizer Inc., Ausio harmaceuticals, LLC, EndoCeutics, Inc., Edgemont Pharmaceuticals, LLC and many others.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Forecasting the Industrial Analysis and Upcoming Market Trends of Vasomotor Symptoms of Menopause till 2024 here

News-ID: 422214 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Vasomotor

Vasomotor Symptoms of Menopause Market to be at Forefront by 2024
Menopause is the stage during which women stop producing ovaries and there is an end of the fertile phase. It occurs in 85% of premenopausal women during their late 40s, resulting in the cessation of their menstrual cycle. Due to the cessation of menstrual flow, the production of estrogen decreases and gonadotropin increases, which gives rise to various physiological and psychological changes, called vasomotor symptoms. Vasomotor symptoms of menopause are
Vasomotor Symptoms of Menopause Treatment Market Investment Research Report 2016 …
Eggs production process gets halted during the menopause condition, as the body produces less progesterone and estrogen the menstrual cycle slows down and eventually stops this results to various erratic symptoms. Most of the times these symptoms are manageable without clinical treatment but in many cases some form of treatment is required. According to the WHO statistics of 2015, the global sex ration is nearly 101.7, it is an indication
Vasomotor Symptoms of Menopause Treatment Market Trends & Projection to 2024
Vasomotor symptoms of menopause treatment market is expected to grow at healthy growth rate in forecast period due to rise aging population, incidences of vasomotor symptoms of menopause will mostly increase in the near future will boost the market growth. Moreover increasing awareness about medication to treat vasomotor symptoms. Many companies are currently conducting clinical trials to develop drug molecules specific for vasomotor symptoms of menopause. Request for Table of Contents
Latest Trend Of Vasomotor Symptoms of Menopause - Pipeline Review, H2 2017
"The Report Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H2 2017, provides an overview of the Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) pipeline landscape. Vasomotor symptoms of menopause include hot
Vasomotor Symptoms of Menopause Treatment Market to Develop by 2024
Eggs production process gets halted during the menopause condition, as the body produces less progesterone and estrogen the menstrual cycle slows down and eventually stops this results to various erratic symptoms. Most of the times these symptoms are manageable without clinical treatment but in many cases some form of treatment is required. According to the WHO statistics of 2015, the global sex ration is nearly 101.7, it is an indication
Vasomotor Symptoms of Menopause Market Share by Industry Research 2016 - 2024
Global Vasomotor Symptoms of Menopause Market: Overview Menopause is the stage during which women stop producing ovaries and there is an end of the fertile phase. It occurs in 85% of premenopausal women during their late 40s, resulting in the cessation of their menstrual cycle. Due to the cessation of menstrual flow, the production of estrogen decreases and gonadotropin increases, which gives rise to various physiological and psychological changes, called vasomotor